BSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹860.00
- Market cap
- ₹83,705 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 57.5×Sector 52.8×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY
Max Healthcare Institute Employee Stock Options
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.
Other management change announcements
All →Shankara Buildpro Management Change
Shankara Buildpro appointed Whole-time Director Dhananjay Mirlay Srinivas as Managing Director for five years, following the founder's demise. The board outcome reports no financial value.
- Execution
- 5 years (appointment term)
Shankara Building Products Management Change
Shankara Building Products appointed Dhananjay Mirlay Srinivas as Managing Director for five years from November 1, 2026. It follows the death of Founder MD Sukumar Srinivas.
- Execution
- 5 years
Premier Explosives Management Change
Premier Explosives disclosed that Lt. Gen. Peruvemba Ramachandran Kumar ceases as Independent Director on completing his second five-year term, effective close of business on 1 November 2026. The company placed on record its appreciation for his contributions.
Axis Bank Management Change
Axis Bank disclosed that Independent Director Girish Paranjpe ceased to be a director on completion of his tenure, effective close of business on 1 November 2026. No monetary value is involved in this change.
KSB Management Change
KSB Limited announced Uday Joshi's designation as General Manager – Project Contract Management from November 1, 2026. It also disclosed the superannuation cessation of Mukesh Pattewar as Head – Project and Contract Management, effective December 31, 2026.
Oil And Natural Gas Corporation Management Change
ONGC disclosed that Executive Director Sanjay Kumar Singh retires on superannuation effective 1 November 2026. Deepali Masirkar joins as Executive Director on deputation from 28 October 2026.